SEC Form 4 · accession 0001179110-18-001327
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2018 | M | 19,200 | $13.40 | A | 32,440 | D | |
| Common Stock | Jan 30, 2018 | S | 16,264 | $18.00 | D | 16,176 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.40 | Jan 30, 2018 | M | 19,200 | D | Jun 5, 2009 | Jun 5, 2018 | Common Stock | 19,200 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.